Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GDA | Q9Y2T3 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 4/20 | 0.41 |
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | PAX8 | Q06710 | 3/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | MMP9 | P14780 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | GAA | P10253 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | XDH | P47989 | 4/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | NAMPT | P43490 | 1/20 | 0.35 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.35 |
| ▸ | PARP1 | P09874 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5702243 | 0.81 | GDA (0.36) | GDALMNAALDH1A1SMN1; SMN2KDM4E | |
| SCHEMBL23902837 | 0.81 | DPP4 (0.40) | GDALMNATSHRALDH1A1PAX8 | |
| SCHEMBL23902839 | 0.81 | DPP4 (0.40) | GDALMNATSHRALDH1A1PAX8 | |
| SCHEMBL23902838 | 0.74 | MEN1 (0.34) | GDALMNAALDH1A1SMN1; SMN2MEN1 | |
| SCHEMBL23902836 | 0.74 | CYP3A4 (0.33) | GDALMNAALDH1A1KDM4EMEN1 | |
| SCHEMBL1924234 | 0.73 | TSHR (0.47) | GDALMNATSHRALDH1A1SMN1; SMN2 | |
| SCHEMBL9669161 | 0.72 | — | — | |
| SCHEMBL755097 | 0.72 | — | — | |
| SCHEMBL9044558 | 0.72 | — | — | |
| SCHEMBL13219030 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8785654-B2 | Method for production of N-(2-amino-1,2-dicyanovinyl)imidates, method for production of N-(2-amino-1,2-dicyanovinyl)formamidine, and method for production of aminoimidazole derivatives | NIPPON SODA CO., LTD. (JP) | 2014-07-22 | — | — | US | disclosed |
| US-8273899-B2 | Method for production of N-(2-amino-1,2-dicyanovinyl)imidates, method for production of N-(2-amino-1,2-dicyanovinyl)formamidine, and method for production of aminoimidazole derivatives | NIPPON SODA CO., LTD. (JP) | 2012-09-25 | — | — | US | disclosed |
| US-8258333-B2 | Method for production of N-(2-amino-1,2-dicyanovinyl)imidates, method for production of N-(2-amino-1,2-dicyanovinyl)formamidine, and method for production of aminoimidazole derivatives | NIPPON SODA CO., LTD. (JP) | 2012-09-04 | — | — | US | disclosed |
| US-20120142957-A1 | METHOD FOR PRODUCTION OF N-(2-AMINO-1,2-DICYANOVINYL)IMIDATES, METHOD FOR PRODUCTION OF N-(2-AMINO-1,2-DICYANOVINYL)FORMAMIDINE, AND METHOD FOR PRODUCTION OF AMINOIMIDAZOLE DERIVATIVES | NIPPON SODA CO., LTD. (JP) | 2012-06-07 | — | — | US | disclosed |
| US-20120130083-A1 | METHOD FOR PRODUCTION OF N-(2-AMINO-1,2-DICYANOVINYL)IMIDATES, METHOD FOR PRODUCTION OF N-(2-AMINO-1,2-DICYANOVINYL)FORMAMIDINE, AND METHOD FOR PRODUCTION OF AMINOIMIDAZOLE DERIVATIVES | NIPPON SODA CO., LTD. (JP) | 2012-05-24 | — | — | US | disclosed |
| EP-2138480-B1 | METHOD FOR PRODUCTION OF N-(2-AMINO-1,2-DICYANOVINYL)IMIDATES AND METHOD FOR PRODUCTION OF AMINOIMIDAZOLE DERIVATIVES | NIPPON SODA CO (JP) | 2011-10-12 | — | — | EP | disclosed |
| US-20100087655-A1 | METHOD FOR PRODUCTION OF N-(2-AMINO-1,2-DICYANOVINYL)IMIDATES, METHOD FOR PRODUCTION OF N-(2-AMINO-1,2-DICYANOVINYL)FORMAMIDINE, AND METHOD FOR PRODUCTION OF AMINOIMIDAZOLE DERIVATIVES | NIPPON SODA CO., LTD (JP) | 2010-04-08 | — | — | US | disclosed |
| EP-2138480-A1 | METHOD FOR PRODUCTION OF N-(2-AMINO-1,2-DICYANOVINYL)IMIDATE, METHOD FOR PRODUCTION OF N-(2-AMINO-1,2-DICYANOVINYL)FORMAMIDINE, AND METHOD FOR PRODUCTION OF AMINOIMIDAZOLE DERIVATIVE | Nippon Soda Co., Ltd. (JP) | 2009-12-30 | — | — | EP | disclosed |
| EP-1215206-B1 | PROCESSES FOR THE PREPARATION OF 4(5)-AMINO-5(4)-CARBOXAMIDOIMIDAZOLES AND INTERMEDIATES THEREOF | NIPPON SODA CO (JP) | 2006-08-02 | — | — | EP | disclosed |
| CN-1238338-C | Process for the preparation of 4(5)-amino-5(4)carboxamidoimidoimidazoles and intermediates thereof | NIPPON SODA CO (JP) | 2006-01-25 | — | — | CN | disclosed |
| US-6797828-B1 | Processes for the preparation of 4(5)-amino-5(4)-carboxamidoimidazoles and intermediates thereof | NIPPON SODA CO. LTD. (JP) | 2004-09-28 | — | — | US | disclosed |
| CN-1502604-A | Process for the preparation of 4(5)-amino-5(4)carboxamidoimidoimidazoles and intermediates thereof | �ձ�������ʽ���� | 2004-06-09 | — | — | CN | disclosed |
| CN-1150169-C | Process for the preparation of 4(5) -amino-5 (4) -carbamoylimidazoles and intermediates thereof | �ձ�������ʽ���� | 2004-05-19 | — | — | CN | disclosed |
| CN-1374951-A | Process for the preparation of 4(5) -amino-5 (4) -carbamoylimidazoles and intermediates thereof | NIPPON SODA CO (JP) | 2002-10-16 | — | — | CN | disclosed |
| EP-1215206-A1 | PROCESSES FOR THE PREPARATION OF 4(5)-AMINO-5(4)-CARBOXAMIDOIMIDAZOLES AND INTERMEDIATES THEREOF | NIPPON SODA CO., LTD. (JP) | 2002-06-19 | — | — | EP | disclosed |
| US-4042703-A | 4-NITRO-5-CARBAMOYL-IMIDAZOLE DERIVATIVES | CIBA-GEIGY CORPORATION (US) | 1977-08-16 | — | — | US | disclosed |
| US-4042703-A | 4-NITRO-5-CARBAMOYL-IMIDAZOLE DERIVATIVES | CIBA-GEIGY CORPORATION (US) | 1977-08-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100087655-A1 | METHOD FOR PRODUCTION OF N-(2-AMINO-1,2-DICYANOVINYL)IMIDATES, METHOD FOR PRODUCTION OF N-(2-AMINO-1,2-DICYANOVINYL)FORMAMIDINE, AND METHOD FOR PRODUCTION OF AMINOIMIDAZOLE DERIVATIVES | NAAA, ITPA, GART | GDA 313/4885LMNA 1944/4885TSHR 4647/4885 |
| US-20120142957-A1 | METHOD FOR PRODUCTION OF N-(2-AMINO-1,2-DICYANOVINYL)IMIDATES, METHOD FOR PRODUCTION OF N-(2-AMINO-1,2-DICYANOVINYL)FORMAMIDINE, AND METHOD FOR PRODUCTION OF AMINOIMIDAZOLE DERIVATIVES | NIT2, NPM1, NAT1 | GDA 2020/4885LMNA 2328/4885TSHR 4004/4885 |
| US-20120130083-A1 | METHOD FOR PRODUCTION OF N-(2-AMINO-1,2-DICYANOVINYL)IMIDATES, METHOD FOR PRODUCTION OF N-(2-AMINO-1,2-DICYANOVINYL)FORMAMIDINE, AND METHOD FOR PRODUCTION OF AMINOIMIDAZOLE DERIVATIVES | NCL, NCLN, NIT2 | GDA 1437/4885LMNA 805/4885TSHR 4361/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.